Lipoproteína de baixa densidade (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lipoproteína de baixa densidade" in Galician language version.

refsWebsite

Global rank Galician rank

15nih.gov

4^th place

6^th place

10doi.org

2^nd place

7^th place

7web.archive.org

1^st place

3americanheart.org

low place

6,370^th place

2clinchem.org

low place

5,389^th place

2onlinejacc.org

low place

1rpi.edu

7,240^th place

3,969^th place

1nejm.org

2,374^th place

1,808^th place

1jlr.org

low place

5,642^nd place

1plosone.org

4,730^th place

1,207^th place

1wiley.com

222^nd place

134^th place

1nbcnews.com

137^th place

672^nd place

1archive.org

6^th place

8^th place

1liposcience.com

low place

1mesa-nhlbi.org

low place

americanheart.org

LDL and HDL Cholesterol: What's Bad and What's Good?
"Cholesterol Levels". American Heart Association. Consultado o 2009-11-14.
"What Do My Cholesterol Levels Mean?" (PDF). American Heart Association. September 2007. Consultado o 2009-11-14.

archive.org

Superko HR, Nejedly M, Garrett B (2002). "Small LDL and its clinical importance as a new CAD risk factor: a female case study". Progress in Cardiovascular Nursing 17 (4): 167–73. PMID 12417832. doi:10.1111/j.0889-7204.2002.01453.x.

clinchem.org

Warnick GR, Knopp RH, Fitzpatrick V, Branson L (January 1990). "Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints". Clinical Chemistry 36 (1): 15–9. PMID 2297909. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
Friedewald WT, Levy RI, Fredrickson DS (June 1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge". Clinical Chemistry 18 (6): 499–502. PMID 4337382. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.

doi.org

dx.doi.org

Dashti M, Kulik W, Hoek F, Veerman EC, Peppelenbosch MP, Rezaee F. (2011). "A phospholipidomic analysis of all defined human plasma lipoproteins.". Sci Rep. 1 (139). PMC 3216620. PMID 22355656. doi:10.1038/srep00139.
Dashty M, Motazacker MM, Levels J, de Vries M, Mahmoudi M, Peppelenbosch MP, Rezaee F. (2014). "Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism.". Thromb Haemost. 23 (111): 518–530. PMID 24500811. doi:10.1160/TH13-02-0178.
Kumar V, Butcher SJ, Katrina O,Engelhardt P,Heikkonen J, Kaski K, Ala-Korpela M, Kovanen PT. (May 2011). "Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature". PLoS ONE 6 (5): e18841. PMC 3090388. PMID 21573056. doi:10.1371/journal.pone.0018841.
Peterson MM, Mack JL, Hall PR; et al. (December 2008). "Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection". Cell Host & Microbe 4 (6): 555–66. PMC 2639768. PMID 19064256. doi:10.1016/j.chom.2008.10.001.
Superko HR, Nejedly M, Garrett B (2002). "Small LDL and its clinical importance as a new CAD risk factor: a female case study". Progress in Cardiovascular Nursing 17 (4): 167–73. PMID 12417832. doi:10.1111/j.0889-7204.2002.01453.x.
Otvos J (June 1999). "Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy". Clin Cardiol 22 (6 Suppl): II21–7. PMID 10376193. doi:10.1002/clc.4960221405.
Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J (outubro 2003). "Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula". Clinical Biochemistry 36 (7): 499–504. PMID 14563441. doi:10.1016/S0009-9120(03)00117-6.
Shepherd J, Cobbe SM, Ford I; et al. (novembro de 1995). "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group". The New England Journal of Medicine 333 (20): 1301–7. PMID 7566020. doi:10.1056/NEJM199511163332001.
William E. Boden, M.D.; et al. (April 2007). "Optimal Medical Therapy with or without PCI for Stable Coronary Disease". The New England Journal of Medicine 356 (15): 1503–1516. PMID 17387127. doi:10.1056/NEJMoa070829.
Krauss RM (August 2010). "Lipoprotein subfractions and cardiovascular disease risk". Current Opinion in Lipidology 21 (4): 305–11. PMID 20531184. doi:10.1097/MOL.0b013e32833b7756.

jlr.org

Segrest JP, Jones MK, De Loof H, Dashti N (September 2001). "Structure of apolipoprotein B-100 in low density lipoproteins". Journal of Lipid Research 42 (9): 1346–67. PMID 11518754. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.

liposcience.com

http://www.liposcience.com/userfiles/content/files/weightofevidence.pdf^{[Ligazón morta]}

mesa-nhlbi.org

nbcnews.com

"Bad cholesterol its not what you think" (en inglés). Arquivado dende o orixinal o 18 de xuño de 2018. Consultado o 27 de xuño de 2018.

nejm.org

http://www.nejm.org/doi/full/10.1056/NEJM198705283162204

nih.gov

ncbi.nlm.nih.gov

Dashti M, Kulik W, Hoek F, Veerman EC, Peppelenbosch MP, Rezaee F. (2011). "A phospholipidomic analysis of all defined human plasma lipoproteins.". Sci Rep. 1 (139). PMC 3216620. PMID 22355656. doi:10.1038/srep00139.
Dashty M, Motazacker MM, Levels J, de Vries M, Mahmoudi M, Peppelenbosch MP, Rezaee F. (2014). "Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism.". Thromb Haemost. 23 (111): 518–530. PMID 24500811. doi:10.1160/TH13-02-0178.
Segrest JP, Jones MK, De Loof H, Dashti N (September 2001). "Structure of apolipoprotein B-100 in low density lipoproteins". Journal of Lipid Research 42 (9): 1346–67. PMID 11518754. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
Kumar V, Butcher SJ, Katrina O,Engelhardt P,Heikkonen J, Kaski K, Ala-Korpela M, Kovanen PT. (May 2011). "Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature". PLoS ONE 6 (5): e18841. PMC 3090388. PMID 21573056. doi:10.1371/journal.pone.0018841.
Peterson MM, Mack JL, Hall PR; et al. (December 2008). "Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection". Cell Host & Microbe 4 (6): 555–66. PMC 2639768. PMID 19064256. doi:10.1016/j.chom.2008.10.001.
Superko HR, Nejedly M, Garrett B (2002). "Small LDL and its clinical importance as a new CAD risk factor: a female case study". Progress in Cardiovascular Nursing 17 (4): 167–73. PMID 12417832. doi:10.1111/j.0889-7204.2002.01453.x.
Warnick GR, Knopp RH, Fitzpatrick V, Branson L (January 1990). "Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints". Clinical Chemistry 36 (1): 15–9. PMID 2297909. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
Otvos J (June 1999). "Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy". Clin Cardiol 22 (6 Suppl): II21–7. PMID 10376193. doi:10.1002/clc.4960221405.
Friedewald WT, Levy RI, Fredrickson DS (June 1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge". Clinical Chemistry 18 (6): 499–502. PMID 4337382. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J (outubro 2003). "Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula". Clinical Biochemistry 36 (7): 499–504. PMID 14563441. doi:10.1016/S0009-9120(03)00117-6.
Shepherd J, Cobbe SM, Ford I; et al. (novembro de 1995). "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group". The New England Journal of Medicine 333 (20): 1301–7. PMID 7566020. doi:10.1056/NEJM199511163332001.
William E. Boden, M.D.; et al. (April 2007). "Optimal Medical Therapy with or without PCI for Stable Coronary Disease". The New England Journal of Medicine 356 (15): 1503–1516. PMID 17387127. doi:10.1056/NEJMoa070829.
Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy.
Krauss RM (August 2010). "Lipoprotein subfractions and cardiovascular disease risk". Current Opinion in Lipidology 21 (4): 305–11. PMID 20531184. doi:10.1097/MOL.0b013e32833b7756.

nhlbi.nih.gov

"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary" (PDF). National Heart, Lung, and Blood Institute (NHLBI). National Institutes of Health. May 2001.

onlinejacc.org

content.onlinejacc.org

John D. Brunzell, MD, FACP, Michael Davidson, MD, FACC, Curt D. Furberg, MD, PhD, Ronald B. Goldberg, MD, Barbara V. Howard, PhD, James H. Stein, MD, FACC, FACP and Joseph L. Witztum, MD Lipoprotein Management in Patients With Cardiometabolic Risk, J Am Coll Cardiol, 2008; 51:1512-1524. [1] Arquivado 27 de febreiro de 2012 en Wayback Machine.
"Copia arquivada". Arquivado dende o orixinal o 27 de febreiro de 2012. Consultado o 15 de febreiro de 2015.

plosone.org

Kumar V, Butcher SJ, Katrina O,Engelhardt P,Heikkonen J, Kaski K, Ala-Korpela M, Kovanen PT. (May 2011). "Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature". PLoS ONE 6 (5): e18841. PMC 3090388. PMID 21573056. doi:10.1371/journal.pone.0018841.

rpi.edu

"Copia arquivada". Arquivado dende o orixinal o 04 de xullo de 2017. Consultado o 15 de febreiro de 2015.

web.archive.org

"Copia arquivada". Arquivado dende o orixinal o 04 de xullo de 2017. Consultado o 15 de febreiro de 2015.
Segrest JP, Jones MK, De Loof H, Dashti N (September 2001). "Structure of apolipoprotein B-100 in low density lipoproteins". Journal of Lipid Research 42 (9): 1346–67. PMID 11518754. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
"Bad cholesterol its not what you think" (en inglés). Arquivado dende o orixinal o 18 de xuño de 2018. Consultado o 27 de xuño de 2018.
Warnick GR, Knopp RH, Fitzpatrick V, Branson L (January 1990). "Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints". Clinical Chemistry 36 (1): 15–9. PMID 2297909. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
John D. Brunzell, MD, FACP, Michael Davidson, MD, FACC, Curt D. Furberg, MD, PhD, Ronald B. Goldberg, MD, Barbara V. Howard, PhD, James H. Stein, MD, FACC, FACP and Joseph L. Witztum, MD Lipoprotein Management in Patients With Cardiometabolic Risk, J Am Coll Cardiol, 2008; 51:1512-1524. [1] Arquivado 27 de febreiro de 2012 en Wayback Machine.
Friedewald WT, Levy RI, Fredrickson DS (June 1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge". Clinical Chemistry 18 (6): 499–502. PMID 4337382. Arquivado dende o orixinal o 12 de setembro de 2019. Consultado o 15 de febreiro de 2015.
"Copia arquivada". Arquivado dende o orixinal o 27 de febreiro de 2012. Consultado o 15 de febreiro de 2015.

wiley.com

onlinelibrary.wiley.com

http://onlinelibrary.wiley.com/doi/10.1002/clc.4960280510/pdf